Background: Type 2 diabetes (T2DM) in pregnancy is associated with poor perinatal outcomes; however, there are limited data on outcomes of continuous glucose monitoring (CGM) use in this population. Objective: We reviewed the literature on studies reporting CGM outcomes in pregnant women with T2DM. We aimed to synthesise in a narrative review, the effects of CGM on glycaemic and perinatal outcomes as well as current research gaps. Results: Of 34 articles screened, three reported CGM outcomes in T2DM pregnancies compared to self-monitoring of blood glucose (SMBG). Other feasibility and mixed population studies were also reviewed. CGM in T2DM has good feasibility, acceptability, and improved glycaemic control beyond SMBG. There were limited data to draw conclusions on its effect on maternal and fetal outcomes. Conclusion: Further studies of perinatal outcomes in pregnant women with T2DM are required to determine the impact of improved glycaemia with CGM.
CotonSJNazarethIPetersenI. A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012. BMJ Open2016; 6: e009494.
DeitchJYatesCJHamblinPS, et al.Prevalence of gestational diabetes mellitus, maternal obesity and associated perinatal outcomes over 10 years in an Australian tertiary maternity provider. Diabetes Res Clin Pract2023; 203: 110793.
4.
MurphyHRHowgateCO'KeefeJ, et al.Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol2021; 9: 153–164.
5.
MackinSTNelsonSMKerssensJJ, et al.Diabetes and pregnancy: national trends over a 15 year period. Diabetologia2018; 61: 1081–1088.
6.
MacintoshMCFlemingKMBaileyJA, et al.Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ-Brit Med J2006; 333: 77.
7.
WilkieGMelnikVBrainardL, et al.Continuous glucose monitor use in type 2 diabetes mellitus in pregnancy and perinatal outcomes: a systematic review and meta-analysis. Am J Obstet Gynecol MFM2023; 5: 100969.
8.
FeigDSDonovanLECorcoyR, et al.Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet2017; 390: 2347–2359.
9.
MajewskaAStanirowskiPJWielgośM,et al.Efficacy of continuous glucose monitoring on glycaemic control in pregnant women with gestational diabetes mellitus-a systematic review. J Clin Med2022; 11: 2932.
10.
García-MorenoRMBenítez-ValderramaPBarquielB, et al.Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials. Diabet Med2022; 39: e14703.
11.
FuntanillaVDCandidatePCaliendoT,et al.Continuous glucose monitoring: a review of available systems. Pharmacol Ther2019; 44: 550–553.
12.
BalsellsMGarcía-PattersonAGichI,et al.Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab2009; 94: 4284–4291.
13.
MurphyHRSteelSARolandJM, et al.Obstetric and perinatal outcomes in pregnancies complicated by type 1 and type 2 diabetes: influences of glycaemic control, obesity and social disadvantage. Diabet Med2011; 28: 1060–1067.
14.
YooJHKimJH. Advances in continuous glucose monitoring and integrated devices for management of diabetes with insulin-based therapy: improvement in glycemic control. Diabetes Metab J2023; 47: 27–41.
BattelinoTDanneTBergenstalRM, et al.Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care2019; 42: 1593–1603.
18.
RadinMS. Pitfalls in hemoglobin A1c measurement: when results may be misleading. J Gen Intern Med2014; 29: 388–394.
19.
DaneseEMontagnanaMNouvenneA, et al.Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes. J Diabetes Sci Technol2015; 9: 169–176.
20.
MendesNAlvesMAndradeR, et al.Association between glycated albumin, fructosamine, and HbA1c with neonatal outcomes in a prospective cohort of women with gestational diabetes mellitus. Int J Gynaecol Obstet2019; 146: 326–332.
21.
KristensenKÖggeLESengpielV, et al.Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies. Diabetologia2019; 62: 1143–1153.
22.
VoormolenDNDeVriesJHSansonRME, et al.Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes Obes Metab2018; 20: 1894–1902.
23.
LiSYGuoHZhangY, et al.Effects of intermittently scanned continuous glucose monitoring on blood glucose control and the production of urinary ketone bodies in pregestational diabetes mellitus. Diabetol Metab Syndr2021; 13: 39.
24.
SecherALRingholmLAndersenHU. The effect of realtime continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013; 36: 1877–1883.
25.
McLeanASinhaABarrE,et al.Feasibility and acceptability of intermittently scanned continuous glucose monitoring for women with type 2 diabetes in pregnancy. J Diabetes Sci Technol2023; 17: 256–258.
26.
SecherALMadsenABRingholmL, et al.Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes. Diabet Med2012; 29: 272–277.
27.
MurphyHRRaymanGDuffieldK, et al.Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007; 30: 2785–2791.
28.
McLachlanKJenkinsAO'NealD. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy. Aust N Z J Obstet Gynaecol2007; 47: 186–190.
29.
WilkieGLMelnikVBrainardL, et al.Perinatal outcomes associated with continuous glucose monitor use in type 2 diabetes mellitus. Am J Obstet Gynecol2023; 228(1): S479.
30.
SecherALRingholmLAndersenHU, et al.The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013; 36: 1877–1883.
31.
MurphyHRRaymanGLewisK, et al.Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ-Brit Med J2008; 337: a1680.
32.
YamamotoJMMurphyHR. Benefits of real-time continuous glucose monitoring in pregnancy. Diabetes Technol Ther2021; 23: S8–S14.
33.
TumminiaAMilluzzoAFestaC, et al.Efficacy of flash glucose monitoring in pregnant women with poorly controlled pregestational diabetes (FlashMom): a randomized pilot study. Nutr Metab Cardiovasc Dis2021; 31: 1851–1859.
Fishel BartalMCornthwaiteJAGhafirD, et al.Time in range and pregnancy outcomes in people with diabetes using continuous glucose monitoring. Am J Perinatol2023; 40: 461–466.
36.
CitroFNicoliFBianchiC, et al.Continuous glucose monitoring metrics and neonatal outcomes in pregnant women with insulin treated diabetes. Diabetes Technol Ther2023; 25: A58.
37.
SanusiAXueYMcIlwraithC, et al.Association between continuous glucose monitoring metrics and perinatal outcomes in pregnancies complicated by pregestational diabetes. Am J Obstet Gynecol2022; 226(1): S457.
38.
BrocatoBHowardHMcIlwraithC, et al.Glycemic control according to continuous glucose monitoring (CGM): does time of day matter?Am J Obstet Gynecol2022; 226(1): S337–S338.
39.
Agha-JaffarROliverNSackeyA, et al.Potential benefits of continuous glucose monitoring in predicting fetal outcomes in pregnant diabetic women. Diabetes Technol Ther2015; 17: A134.
40.
LawGREllisonGTSecherAL, et al.Analysis of continuous glucose monitoring in pregnant women with diabetes: distinct temporal patterns of glucose associated with large-for-gestational-age infants. Diabetes Care2015; 38: 1319–1325.
